Literature DB >> 19433914

Sequence variants of chemokine receptor genes and susceptibility to HIV-1 infection.

M Parczewski1, M Leszczyszyn-Pynka, M Kaczmarczyk, G Adler, A Binczak-Kuleta, B Loniewska, A Boron-Kaczmarska, A Ciechanowicz.   

Abstract

Genetic susceptibility to HIV infection was previously proven to be influenced by some chemokine receptor polymorphisms clustering on chromosome 3p21. Here the influence of 5 genetic variants was studied: Delta32 CCR5, G(-2459)A CCR5, G190A CCR2, G744A CX3CR1 and C838T CX3CR1. They were screened in a cohort of 168 HIV-1 positive adults [HIV(+) group] and 151 newborns [control group] from northwestern Poland. PCR-RFLP was performed to screen for the variants (except for Delta32 CCR5 polymorphism, where PCR fragment size was sufficient to identify the alleles) and then electrophoresed on agarose gel to determine fragment size. Distribution of genotypes and alleles was not significantly different between the groups except for the CCR5 polymorphisms, with the Delta32 allele and the (-2459)A CCR5 allele more frequent among neonates than in the HIV(+) group. No Delta32/Delta32 homozygotes were found in the HIV(+) group, but 16.1 percent were Delta32/wt heterozygotes. In the control group, 1.3 percent; were Delta32/Delta32 homozygotes and 26.0percent were Delta32/wt heterozygotes. Linkage between the chemokine polymorphisms was calculated using the most informative loci for haplotype reconstruction. Haplotypes containing Delta32 CCR5, 190G CCR2 and 744A CX3CR1 were found to be significantly more common in the control group. This suggests an association between these haplotypes and resistance to HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433914     DOI: 10.1007/BF03195668

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   2.653


  35 in total

1.  A new multiplex PCR strategy for the simultaneous determination of four genetic polymorphisms affecting HIV-1 disease progression.

Authors:  T B Kristiansen; T B Knudsen; S Ohlendorff; J Eugen-Olsen
Journal:  J Immunol Methods       Date:  2001-06-01       Impact factor: 2.303

2.  Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease.

Authors:  A Rector; S Vermeire; I Thoelen; E Keyaerts; F Struyf; R Vlietinck; P Rutgeerts; M Van Ranst
Journal:  Hum Genet       Date:  2001-03       Impact factor: 4.132

3.  Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection.

Authors:  Sadeep Shrestha; Steffanie A Strathdee; Noya Galai; Taras Oleksyk; M Daniele Fallin; Shruti Mehta; Daniel Schaid; David Vlahov; Stephen J O'Brien; Michael W Smith
Journal:  J Infect Dis       Date:  2005-11-22       Impact factor: 5.226

4.  Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.

Authors:  Jianming Tang; Brent Shelton; Nina J Makhatadze; Yuting Zhang; Margaret Schaen; Leslie G Louie; James J Goedert; Eric C Seaberg; Joseph B Margolick; John Mellors; Richard A Kaslow
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes.

Authors:  J Rappaport; Y Y Cho; H Hendel; E J Schwartz; F Schachter; J F Zagury
Journal:  Lancet       Date:  1997-03-29       Impact factor: 79.321

Review 6.  AIDS: a role for host genes.

Authors:  S J O'Brien
Journal:  Hosp Pract (1995)       Date:  1998-07-15

7.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Authors:  G Alkhatib; C Combadiere; C C Broder; Y Feng; P E Kennedy; P M Murphy; E A Berger
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

8.  Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1.

Authors:  C Combadiere; K Salzwedel; E D Smith; H L Tiffany; E A Berger; P M Murphy
Journal:  J Biol Chem       Date:  1998-09-11       Impact factor: 5.157

9.  Influence of the CCR2-V64I polymorphism on human immunodeficiency virus type 1 coreceptor activity and on chemokine receptor function of CCR2b, CCR3, CCR5, and CXCR4.

Authors:  B Lee; B J Doranz; S Rana; Y Yi; M Mellado; J M Frade; C Martinez-A; S J O'Brien; M Dean; R G Collman; R W Doms
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression.

Authors:  Miyuki Nishimura; Hisanori Umehara; Takashi Nakayama; Osamu Yoneda; Kunio Hieshima; Mayumi Kakizaki; Naochika Dohmae; Osamu Yoshie; Toshio Imai
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

View more
  9 in total

1.  Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population.

Authors:  Andrew J Gawron; Angela J Fought; Jolanta Lissowska; Weimin Ye; Xiao Zhang; Wong-Ho Chow; Laura E Beane Freeman; Lifang Hou
Journal:  Scand J Gastroenterol       Date:  2010-11-22       Impact factor: 2.423

2.  Impact of CCR2 and SDF1 polymorphisms on disease progression in HIV-infected subjects in Thailand.

Authors:  Palanee Ammaranond; Sayompoo Sanguansitthianan; Poonlaph Phaengchomduan; Chanachai Sae-Lee; Sirimarn Mardkhumchan
Journal:  J Clin Lab Anal       Date:  2013-01       Impact factor: 2.352

3.  CCR2 polymorphism and HIV: mutation in both mother and child is associated with higher transmission.

Authors:  Marie Nicole Ngoufack; Céline N Nkenfou; Barbara A Tiedeu; Georges Nguefack-Tsague; Linda C Mekue Mouafo; Beatrice Dambaya; Carine N Nguefeu; Elvis N Ndzi; Serge C Billong; Wilfred F Mbacham; Alexis Ndjolo
Journal:  Int J Biochem Mol Biol       Date:  2019-10-15

4.  Frequency of CCR5Δ32 allele in healthy Bosniak population.

Authors:  Grażyna Adler; Amina Valjevac; Karolina Skonieczna-Żydecka; Mirela Mackic-Djurovic; Miłosz Parczewski; Anna Urbańska; Nermin Nusret Salkic
Journal:  Bosn J Basic Med Sci       Date:  2014-08-28       Impact factor: 3.363

5.  Formal reasoning on qualitative models of coinfection of HIV and Tuberculosis and HAART therapy.

Authors:  Anil Sorathiya; Andrea Bracciali; Pietro Liò
Journal:  BMC Bioinformatics       Date:  2010-01-18       Impact factor: 3.169

6.  Risk of all-cause mortality in HIV infected patients is associated with clinical, immunologic predictors and the CCR5 Δ32 deletion.

Authors:  Milosz Parczewski; Dorota Bander; Magdalena Leszczyszyn-Pynka; Anna Urbanska; Mariusz Kaczmarczyk; Andrzej Ciechanowicz; Anna Boron-Kaczmarska
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

7.  Risk of HIV Infection and Lethality Are Decreased in CCR5del32  Heterozygotes: Focus Nosocomial Infection Study and Meta-analysis.

Authors:  S A Borinskaya; Zh M Kozhekbaeva; A V Zalesov; E V Olseeva; A R Maksimov; S I Kutsev; M M Garaev; A V Rubanovich; N K Yankovsky
Journal:  Acta Naturae       Date:  2012-01       Impact factor: 1.845

8.  The temporal increase in HIV-1 non-R5 tropism frequency among newly diagnosed patients from northern Poland is associated with clustered transmissions.

Authors:  Miłosz Parczewski; Magdalena Leszczyszyn-Pynka; Magdalena Witak-Jędra; Katarzyna Maciejewska; Sławomira Myślińska; Anna Urbańska
Journal:  J Int AIDS Soc       Date:  2015-08-20       Impact factor: 5.396

9.  Possible Impact of 190G > A CCR2 and Δ32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity-A Preliminary Report.

Authors:  Maria Ganczak; Karolina Skonieczna-Żydecka; Marzena Drozd-Dąbrowska; Grażyna Adler
Journal:  Int J Environ Res Public Health       Date:  2017-02-08       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.